Events
The Fate of FDA Authority: Addressing Recent Supreme Court Decisions on Mifepristone, Chevron, and Beyond
July 11, 2024

On July 11, Axinn partner Chad Landmon will participate in a Food and Drug Law Institute webinar, "The Fate of FDA Authority: Addressing Recent Supreme Court Decisions on Mifepristone, Chevron, and Beyond."

Participants will review the unanimous decision in the case that challenged FDA’s ability to approve the abortion medication mifepristone (FDA v. Alliance for Hippocratic Medicine), as well as the cases that challenged the Chevron doctrine, where courts deferred to an agency’s interpretation of an ambiguous statute (Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce). 

Click here for more information, including how to register. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.